US Files Complaint Against Gilead Sciences For Patent Infringement

(RTTNews) - The United States government has filed a lawsuit against Gilead Sciences, alleging that the biopharmaceutical company's two HIV drugs, Truvada and Descovy, infringe on four patents owned by the Department of Health and Human Services or HHS.

According to the Department of Justice, the four patents owned by the HHS cover specific drug regimens used for pre-exposure prophylaxis or PrEP, to prevent HIV infection.

PrEP is an HIV prevention method in which people who are HIV-negative take the medicine on a daily basis to mitigate the risk of getting HIV if they are exposed to the virus.

Gilead had originally obtained FDA approvals for Truvada and Descovy to be used solely for treating HIV in combination with other drugs.

The company later sought FDA approval for Truvada and more recently, Descovy, to be used as part of PrEP drug regimens after researchers at the Centers for Disease Control and Prevention or CDC developed the two-drug regimens that could, for the first time, prevent people from becoming infected with HIV.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Июнь 2020    »